Results 111 to 120 of about 17,598 (157)
In vitro susceptibility of cultured human methanogens to lovastatin
International Journal of Antimicrobial Agents, 2017 International audienceLovastatin is a prodrug that is hydrolysed in vivo to beta-hydroxy acid lovastatin, which inhibits 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-Co-A) reductase (HMGR), thereby lowering cholesterol in humans.
Nicholas Armstrong, Michel Drancourt
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Archives of Internal Medicine, 1990
Two patients who developed hypoprothrombinemia and bleeding due to lovastatin-warfarin drug interaction are described. Because of the wider use of lovastatin and warfarin, heightened clinical awareness of this potentially serious interaction must be publicized.
+6 more sources
Two patients who developed hypoprothrombinemia and bleeding due to lovastatin-warfarin drug interaction are described. Because of the wider use of lovastatin and warfarin, heightened clinical awareness of this potentially serious interaction must be publicized.
+6 more sources
Lovastatin for Hypercholesterolemia
Drug Intelligence & Clinical Pharmacy, 1988Lovastatin is the first 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor approved for the treatment of primary hypercholesterolemia. It is indicated as adjunctive therapy to dietary control and should be initiated at 20 mg/d in the evening. With higher dosages, twice-daily dosing is preferred, particularly when the dosage reaches the
F P, Zeller, K C, Uvodich
openaire +2 more sources
The American Journal of Cardiology, 2002
The cholesterol-lowering agents, known as statins, have been in use for 15 years and are among the most commonly prescribed drugs. Animal studies and premarketing clinical trials have given signals of hepatotoxicity, primarily minor elevations in serum alanine aminotransferase enzyme (ALT) levels.
openaire +2 more sources
The cholesterol-lowering agents, known as statins, have been in use for 15 years and are among the most commonly prescribed drugs. Animal studies and premarketing clinical trials have given signals of hepatotoxicity, primarily minor elevations in serum alanine aminotransferase enzyme (ALT) levels.
openaire +2 more sources